Development and characterization of anti-SARS-CoV-2 intravenous immunoglobulin from COVID-19 convalescent plasma

Background: The authors describe the developmental process of intravenous anti-COVID-19 hyperimmune immunoglobulin from anti-SARS-CoV-2 neutralizing antibody-containing plasma. Furthermore, the authors investigated its safety and protective activity in animal models. Materials & methods: The man...

Descripción completa

Detalles Bibliográficos
Autores principales: Razumikhin, Mikhail, Smolyanova, Tatiana, Nikolaeva, Alevtina, Orlova, Ekaterina, Ivanov, Aleksandr, Belyakova, Olga, Vyaznikova, Tatyana, Selezneva, Natalia, Perevozchikov, Anton, Sokolova, Alina, Zubkova, Nataliya, Efimova, Irina, Dolzhikova, Inna, Logunov, Denis, Sakanjan, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328115/
https://www.ncbi.nlm.nih.gov/pubmed/35892311
http://dx.doi.org/10.2217/imt-2022-0015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328115/
https://www.ncbi.nlm.nih.gov/pubmed/35892311
http://dx.doi.org/10.2217/imt-2022-0015

Ejemplares similares